Usefulness of monitoring the circulating Krebs von den Lungen-6 levels to predict the clinical outcome of patients with advanced nonsmall cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors
2008 ◽
Vol 122
(11)
◽
pp. 2612-2620
◽
2019 ◽
Vol 31
(1)
◽
pp. 1-7
◽
2016 ◽
Vol 10
(2)
◽
pp. 152-156
◽
2016 ◽
Vol 28
(2)
◽
pp. 115-121
◽
2015 ◽
Vol 27
(2)
◽
pp. 94-101
◽
2013 ◽
Vol 41
(3)
◽
pp. 573-583
◽
2019 ◽
Vol 16
(8)
◽
pp. 3469-3476
◽
Epidermal growth factor receptor tyrosine kinase inhibitors in early-stage nonsmall cell lung cancer
2015 ◽
Vol 27
(2)
◽
pp. 102-107
◽
2014 ◽
Vol 42
(1)
◽
pp. 191-197
◽
2016 ◽
Vol Volume 10
◽
pp. 3867-3872
◽